Anti-Human/Mouse GOLGA2/GM130 Antibody [A770]
Anti-Human/Mouse GOLGA2/GM130 Antibody [A770] with collaborator-tested evidence for WB, IHC. Read more ›
["WBProduct Description
GOLGA2/GM130 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human, Mouse; host: Rabbit; clonality: Monoclonal; clone: A770; isotype: IgG, κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Peptide. This information is proprietary to PTMab.; purification: Protein A purified; concentration: 1 mg/mL.
Database references: UniProt: Q08379.
Research Use Only.
Key Facts
| Target | GOLGA2/GM130 |
| Also known as | GOLGA, golgin A, GOLGA2, GM130, golgin A2, 130 kDa cis Golgi matrix protein, 130 kDa cis-Golgi matrix protein, Cis golgi matrix protein GM130, Gm130 autoantigen, GOGA2, GOLGA 2, Golgi autoantigen, Golgi autoantigen golgin subfamily a 2, Golgi matrix protein GM130, Golgin 95, Golgin subfamily a 2, Golgin subfamily A member 2, Golgin-95, MGC20672, SY11 protein |
| Concentration | 1 mg/mL |
| Species reactivity | Human, Mouse |
| Observed band | 130 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Tags and Cell Markers, Signal Transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human | ||||||||
| Mouse |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.